Therapy of chronic myelogenous leukemia with related or unrelated donor bone marrow transplantation.

No abstract is available for this paper.

• Publication year

  1992

• Venue

  Leukemia

• Publication date

  1992-11-01

• Fields of study

  Medicine

• Identifiers
  PMID 1434814
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Six variants of HLA-1327 identified by isoelectric focusing

  2004cited by this paper
• Future directions in selection of donors for bone marrow transplantation: role of oligonucleotide genotyping.

  1991cited by this paper
• Selection of unrelated donors for bone marrow transplantation is improved by HLA class II genotyping with oligonucleotide hybridization.

  1991cited by this paper
• PCR-fingerprinting for selection of HLA matched unrelated marrow donors. Collaborating Centres in the IMUST Study.

  1991cited by this paper
• Successful allogeneic transplantation of T-cell-depleted bone marrow from closely HLA-matched unrelated donors.

  1990cited by this paper
• Therapy for chronic myelogenous leukemia with unrelated donor bone marrow transplantation: results in 102 cases.

  1990cited by this paper
• Indications for marrow transplantation in chronic myelogenous leukemia.

  1989cited by this paper
• HLA class II typing by restriction fragment length polymorphism (RFLP) in unrelated bone marrow transplant patients.

  1989cited by this paper
• Bone marrow transplantation for chronic myeloid leukaemia in first chronic phase: importance of a graft‐versus‐leukaemia effect

  1988cited by this paper
• Bone marrow transplantation for patients with chronic myeloid leukemia.

  1986cited by this paper
• Adverse effect of severe marrow fibrosis on hematologic recovery after chemoradiotherapy and allogeneic bone marrow transplantation.

  1986cited by this paper
• High-resolution analysis of the human HLA-DR polymorphism by hybridization with sequence-specific oligonucleotide probes.

  1986cited by this paper
• Marrow transplantation for the treatment of chronic myelogenous leukemia.

  1986cited by this paper
• An improved biochemical method for the analysis of HLA-class I antigens. Definition of new HLA-class I subtypes.

  1986cited by this paper
• Marrow transplantation for stable-phase chronic granulocytic leukemia.

  1984cited by this paper
• Reversal of severe bone marrow fibrosis and osteosclerosis following allogeneic bone marrow transplantation for chronic granulocytic leukaemia

  1982cited by this paper
• Allogeneic bone marrow transplantation for chronic granulocytic leukemia.

  1981cited by this paper
• Disappearance of Ph1-positive cells in four patients with chronic granulocytic leukemia after chemotherapy, irradiation and marrow transplantation from an identical twin.

  1979cited by this paper
• Treatment of chronic granulocytic leukemia by chemotherapy, total body irradiation and allogeneic bone marrow transplantation.

  1978cited by this paper

• Accelerated Phase CML: Outcomes in Newly Diagnosed vs. Progression From Chronic Phase

  2016cites this paper
• study : Presented in part at the 43rd Annual Meeting of The American chronic myelogenous leukemia in myeloid blast crisis: results of a phase II Imatinib induces hematologic and cytogenetic responses in patients with

  2013cites this paper
• Chronic myeloid leukemia: an update of concepts and management recommendations of European LeukemiaNet.

  2009cites this paper
• Evolutionary dynamics of imatinib-treated leukemic cells by stochastic approach

  2008cites this paper
• Chronic Myelogenous Leukemia : A Concise Update

  2003cites this paper
• Imatinib induces durable hematologic and cytogenetic responses in patients with accelerated phase chronic myeloid leukemia: results of a phase 2 study.

  2002cites this paper
• Treatment of philadelphia chromosome-positive, accelerated-phase chronic myelogenous leukemia with imatinib mesylate.

  2002influential citation
• Imatinib induces hematologic and cytogenetic responses in patients with chronic myelogenous leukemia in myeloid blast crisis: results of a phase II study.

  2002influential citation
• Prolonged remission and autologous recovery in two patients with chronic myelogenous leukemia after graft failure of allogeneic bone marrow transplantation

  1998cites this paper
• An in vitro model for cytogenetic conversion in CML. Interferon-alpha preferentially inhibits the outgrowth of malignant stem cells preserved in long-term culture.

  1998cites this paper
• Efficient long-term maintenance of chronic myeloid leukemic cobblestone area forming cells on a murine stromal cell line

  1997cites this paper
• Chronic myelogenous leukemia: a review.

  1996cites this paper
• Related donor marrow transplant for chronic myeloid leukemia: patient characteristics predictive of outcome.

  1996cites this paper
• Cytokine therapy for hematological malignancies.

  1996cites this paper
• Chemotherapy and bone marrow transplantation in the treatment of chronic myelogenous leukemia.

  1994cites this paper
• Therapy of chronic myelogenous leukemia

  1993cites this paper
• Chronic myelogenous leukemia: a concise update.

  1993cites this paper